PubMedCrossRef 8. O’Brien A, Lively T, Chang T, Gorbach S: Purification selleck products of Shigella dysenteriae 1 (Shiga)-like toxin from Escherichia coli O157:H7 strain associated with haemorrhagic colitis. Lancet 1983, 2:573.PubMedCrossRef 9. Smith H, Green P, Parsell Z: Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J Gen Microbiol 1983, 129:3121–3137.PubMed 10. Smith HR, Day NP, Scotland SM, Gross RJ, Rowe B: Phage-determined production of vero cytotoxin in strains of Escherichia coli serogroup O157. Lancet 1984, 1:1242–1243.PubMedCrossRef 11. Allison H: Stx-phages: drivers and mediators of the evolution

of STEC and STEC-like pathogens. Future Microbiol 2007, 2:165–174.PubMedCrossRef 12. Hayashi T, Makino K, Ohnishi M, Kurokawa K, Ishii K, Yokoyama K, Han CG, Ohtsubo E, Nakayama K, Murata T, et al.: Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic

comparison with a laboratory strain K-12. DNA Res 2001, 8:11–22.PubMedCrossRef 13. Los JM, Los M, Wegrzyn G: Bacteriophages carrying Shiga toxin genes: genomic variations, detection and potential treatment of pathogenic bacteria. Future Microbiol 2011, 6:909–924.PubMedCrossRef 14. Allison HE, Sergeant MJ, James CE, Saunders JR, selleck screening library Smith DL, Sharp RJ, Marks TS, McCarthy AJ: Immunity profiles of wild-type and recombinant shiga-like toxin-encoding bacteriophages and characterization of novel double lysogens. Infect Immun 2003, 71:3409–3418.PubMedCrossRef 15. Miyamoto H, Carnitine palmitoyltransferase II Nakai W, Yajima N, Fujibayashi A, Higuchi T, Sato K, Matsushiro A: Sequence analysis of Stx2-converting phage VT2-Sa shows a great divergence in early regulation and replication regions. DNA Res 1999, 6:235–240.PubMedCrossRef 16. Plunkett G, Rose DJ, Durfee TJ, Blattner FR: Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product. J Bacteriol 1999, 181:1767–1778.PubMed 17. Handfield M, Hillman J: In vivo induced antigen technology (IVIAT) and change mediated antigen technology (CMAT). Infect Disord Drug Targets 2006, 6:327–334.PubMedCrossRef 18. James CE, Stanley KN, Allison HE, Flint

HJ, Stewart CS, Sharp RJ, Saunders JR, McCarthy AJ: Lytic and lysogenic infection of diverse Escherichia coli and Shigella strains with a verocytotoxigenic bacteriophage. Appl Environ Microbiol 2001, 67:4335–4337.PubMedCrossRef 19. Lwoff A: Lysogeny. Bacteriol Rev 1953, 17:269–337.PubMed 20. Sato T, Shimizu T, Watarai M, Kobayashi M, Kano S, Hamabata T, www.selleckchem.com/products/azd1080.html Takeda Y, Yamasaki S: Distinctiveness of the genomic sequence of Shiga toxin 2-converting phage isolated from Escherichia coli O157:H7 Okayama strain as compared to other Shiga toxin 2-converting phages. Gene 2003, 309:35–48.PubMedCrossRef 21. Arraiano CM, Bamford J, Brussow H, Carpousis AJ, Pelicic V, Pfluger K, Polard P, Vogel J: Recent advances in the expression, evolution, and dynamics of prokaryotic genomes.